Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
Would you consider consolidative RT in patients with metastatic bladder cancer after near complete response after Keytruda?
Answer from: Radiation Oncologist at Community Practice
Generally, no I wouldn't, as I can't quantify the risk-to-benefit ratio given the paucity of data.
Sign in or Register to read more
20304
Related Questions
Do you offer RT both to the prostate and synchronous oligometastases in de novo oligometastatic prostate cancer?
Can a PSA bounce be seen shortly after SBRT to prostate cancer oligometastases while on androgen deprivation therapy?
What radiation treatments would you offer an older man with unfavorable intermediate-risk prostate cancer, with comorbid conditions, if you don't feel he is a good candidate for full-course radiation therapy with ADT?
What data support the use of continuing GnRH therapy "backbone" in metastatic castration resistant prostate cancer (mCRPC) receiving additional therapies?
How are you integrating Prostox into your practice for prostate patients deciding between SBRT and hypofractionation?
How do you approach Lu-177 use in taxane-naive patients with metastatic prostate cancer?
How would you manage a patient who developed an intraprostatic abscess after SpaceOAR injection, prior to starting radiation?
How do you approach treatment for a patient with an isolated perineal/pubic recurrence of penile SCC s/p definitive surgery?
Is REZUM (water vapor thermotherapy for BPH) safe after EBRT?
For a patient with a rising PSA after prostatectomy with seminal vesicles being negative for disease at surgery, do you ever treat the prostate bed and seminal vesicle bed with different doses in an SIB plan?